Fig. 1.

Mutation and copy number profiling of the clinical cohort of meningiomas developed on cyproterone acetate (CPA). Data are shown for all samples for which array-comparative genomic hybridization (array-CGH) and next-generation sequencing (NGS) were performed. (A) Patient demographic data. (B) Clinical classification. (C) Histopathological findings. (D) Mutation status. (E) Copy number alterations. The cytogenetic abnormality score (CAS) is plotted in the upper row. Unavailable data are represented in dark gray. The gene panel used for sequencing is available in Supplementary Table 1.